It is a chemicals private limited company based in Nagpur, Maharashtra, India, established in 2022.
2022 | Nagpur, Maharashtra, India | ActiveRicrisa Pharmaceuticals Private Limited, a active private limited company, was established on 04 January 2022 in Nagpur, Maharashtra, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230MH2022PTC374333. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Rupali Rahul Kondalkar (Director), Sneha Shyamkant Suryawanshi (Director), Nitesh Madhukar Lad (Director). Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 802, Balaji Nagar, Hingna Nagpur, Digdoh, Nagpur, Maharashtra, 441110.
U24230MH2022PTC374333
374333
04 January 2022
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Ricrisa Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rupali Rahul Kondalkar | Director | 04 Jan 2022 | Current |
| Sneha Shyamkant Suryawanshi | Director | 04 Jan 2022 | Current |
| Nitesh Madhukar Lad | Director | 04 Jan 2022 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Ricrisa Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Ricrisa Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Ricrisa Pharmaceuticals has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ricrisa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ricrisa Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Ricrisa Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
The activity Ricrisa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was completed.
Rupali Rahul Kondalkar was appointed as a Director was appointed as a Director on 04 Jan 2022 & has been associated with this company since 3 years 11 months . was recorded as a recent event.
Sneha Shyamkant Suryawanshi was appointed as a Director was appointed as a Director on 04 Jan 2022 & has been associated with this company since 3 years 11 months . was recorded as a recent event.
The activity Nitesh Madhukar Lad was appointed as a Director was appointed as a Director on 04 Jan 2022 & has been associated with this company since 3 years 11 months . was completed.
Progress on Ricrisa Pharmaceuticals Private Limited was registered on 04 Jan 2022 with Roc Mumbai & aged 3 years 11 months as per MCA records. was documented.
The CIN of Ricrisa Pharmaceuticals Private Limited is U24230MH2022PTC374333.
Ricrisa Pharmaceuticals Private Limited is headquartered at 802, Balaji Nagar, Hingna Nagpur, Digdoh, Nagpur, Maharashtra, 441110.
Ricrisa Pharmaceuticals Private Limited was incorporated on 04 January 2022.
The current directors of Ricrisa Pharmaceuticals Private Limited are
The primary industry of Ricrisa Pharmaceuticals Private Limited is Chemicals.
Ricrisa Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ricrisa Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX